XML 41 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments - Stock Option Plan 2015 (Details) - SOP 2015 - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Jun. 23, 2017
Aug. 25, 2016
Sep. 23, 2015
Apr. 02, 2015
Options              
Outstanding at beginning of year (in shares)     1,794,360        
Granted (in shares)     1,458,300        
Forfeited (in shares)     (110,900)        
Outstanding at end of year (in shares) 3,141,760   3,141,760        
Vested and exercisable at end of year (in shares) 897,159   897,159        
Weighted average exercise price in $ per share              
Outstanding balance at beginning of year (in dollars per share)     $ 7.83        
Granted (in dollars per share)     9.02        
Forfeited (in dollars per share)     8.92        
Outstanding balance at end of year (in dollars per share) $ 8.34   8.34        
Vested and exercisable balance at end of year (in dollars per share) $ 7.67   $ 7.67        
Aggregate intrinsic value              
Vested and exercisable at end of year (in dollars) $ 1,630   $ 1,630        
Options              
Share-Based Payments              
Vesting period     4 years        
Other disclosures              
Share-based compensation expense 4,500 $ 1,600          
Weighted-average grant date fair value (in dollars per share)     $ 5.05        
Fair Value Assumptions              
Expected term of options (in years)     6 years 1 month 6 days        
Dividend yield (as a percent)     0.00%        
Weighted-average remaining contractual life     8 years 8 months 12 days        
Unrecognized compensation expense              
Total unrecognized compensation related to non-vested options (in dollars) $ 11,700   $ 11,700        
Period of recognition of total unrecognized compensation related to options     1 year 4 months 24 days        
Options | First year              
Share-Based Payments              
Vesting period     1 year        
Percentage that vests during the period     25.00%        
Options | Second, third, and fourth years              
Share-Based Payments              
Percentage that vests during the period     75.00%        
Monthly vesting percentage     2.083%        
Common Stock | Nabriva Therapeutics AG ("Nabriva Austria")              
Share-Based Payments              
Maximum number of shares authorized         346,235 177,499 95,000
Common Stock | Redomiciliation Transaction | Nabriva Therapeutics AG ("Nabriva Austria")              
Share-Based Payments              
Number of shares to be awarded for each option when exercised       1      
Ordinary Shares | Redomiciliation Transaction | Nabriva Therapeutics plc ("Nabriva Ireland")              
Share-Based Payments              
Number of shares to be awarded for each option when exercised       10      
Minimum | Options              
Fair Value Assumptions              
Range of expected volatility (as a percent)     55.60%        
Range of risk-free interest rate (as a percent)     1.80%        
Maximum | Options              
Share-Based Payments              
Exercise period     10 years        
Fair Value Assumptions              
Range of expected volatility (as a percent)     62.00%        
Range of risk-free interest rate (as a percent)     2.10%